Shell (SHEL LN) has drawn interest from potential bidders including ExxonMobil (XOM) and LyondellBasell (LYB) for its USD 8bln US chemicals assets sale, according to FT

A strategic asset sale with named strategic bidders rather than financial sponsors is the cleaner variant of divestiture processes: trade buyers typically pay up for synergies, which supports headline valuation but lengthens the antitrust and integration tail. The mix of a supermajor and a commodity chemicals producer in the bidder pool suggests interest spans both the upstream-integrated and pure chemicals reads on the assets, and processes that draw both types have historically seen the chemical specialists stretch further on multiples while the integrated players bid more selectively on feedstock-advantaged sites. The figure cited is a deal size reference rather than a confirmed valuation, so the operative questions are whether the process is a full or partial sale, whether it reaches a signed agreement or stalls on price, and what the proceeds do to the seller's buyback and balance sheet narrative, which has been the primary channel through which European majors' disposals have fed into equity performance. Attribution to a named paper rather than a company statement puts this in the leak-stage category, where the usual sequence is confirmation or denial, then adviser and timeline detail. Worth watching are the peer read-across in US chemicals names and any signal on how carve-out complexity, environmental liabilities in particular, is being allocated.